FIELD: medicine.
SUBSTANCE: invention relates to medicine and represents pharmacologic composition for diarrhea treatment in case of irritate bowels syndrome in women, which contains from 0.002 to 0.02 mg of ramosetron hydrochloride as daily dose or equivalent molar amount of ramosetron or its other pharmacologically acceptable salt as active ingredient.
EFFECT: invention ensures more efficient treatment of diarrhea syndrome in case of irritate bowels syndrome in women.
6 cl, 10 ex
